Changes in the prevalence of U.S. adults using diet, exercise, pharmaceuticals and diet products for weight loss over time: Analysis of NHANES 1999-2018.

PLoS One · 2023 · PMC10581481 · PMID 37847708

Europe PMC DOI

hedged sentence

0.2200

closest p · 4.4× alpha

0.2200

boldest claim

The sentences

did not reach statistical significanceP>0.22not close (p > 0.1)

When prescription weight loss and diet products/supplements were examined separately, there was a general trend for decreased usage in those with obesity, but with the low prevalence of weight loss drug use, these differences did not reach statistical significance (nOB Female: 2.2 to 3.3%; OB Female: 6.9 to 5.9%; nOB Male: 0.1 to 0.3%; OB Male: 2.8 to 1.6%, P>0.22).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.